The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback